02.10.2007 14:11:00
|
Hitachi Medical Systems America Announces FDA Clearance of Its OASIS(TM) MR System
Hitachi Medical Systems America, Inc., a leading provider of diagnostic
imaging equipment, announced FDA clearance to market its Oasis magnetic
resonance imaging (MRI) system, the latest in the company’s
line of MRI products. Oasis features high performance with Hitachi’s
proprietary 1.2 Tesla vertical field magnet technology inclusive of high
magnet homogeneity and higher order active shim, all in an open
architecture magnet design. Oasis provides high performance without
sacrificing patient comfort.
"Oasis is the answer to many of the troubling
product tradeoffs in MR,” said Sheldon
Schaffer, Vice President and General Manager, MR and CT, "With
magnetic field strength of 1.2 Tesla, a high performance gradient system
coupled with an 8-channel Radio Frequency (RF) system and unique
Hitachi-designed RF coils, Oasis provides a platform for high
performance imaging in a comfortable patient setting.” "Oasis reflects Hitachi’s
commitment to providing patient-centric imaging solutions while giving
physicians the diagnostic information they need,”
said Shawn Etheridge, Director of Magnetic Resonance Marketing with
Hitachi, "Patients now have an unrestricted
viewing angle and the diagnostic benefits of the most powerful vertical
field magnet ever designed for whole body clinical use.”
Hitachi Medical Systems America, Inc. (HMSA) markets magnetic resonance
imaging (MRI) systems of Hitachi Medical Corporation, Tokyo, Japan. The
company has more than 1,500 MRI systems installed throughout the United
States and over 3,100 MRI systems installed worldwide. HMSA first
established a leadership position in the medical industry with Open MRI
systems and has expanded their modality offerings to include ultrasound,
and computed tomography.
Hitachi, Ltd., (NYSE:HIT) (TOKYO:6501), headquartered in Tokyo, Japan,
is a leading global electronics company with approximately 384,000
employees worldwide. Fiscal 2006 (ended March 31, 2007) consolidated
revenues totaled 10,247 billion Yen ($86.8 billion). The company offers
a wide range of systems, products and services in market sectors
including information systems, electronic devices, power and industrial
systems, consumer products, materials and financial services. For more
information on Hitachi, please visit the company's website at http://www.hitachi.com.
For more information, contact:
Shawn Etheridge
Director, MR Marketing
Hitachi Medical Systems America
1959 Summit Commerce Park
Twinsburg, OH 44087
800.800.3106
www.hitachimed.com
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.
Nachrichten zu Hitachi Ltd.mehr Nachrichten
29.10.24 |
Ausblick: Hitachi legt Zahlen zum jüngsten Quartal vor (finanzen.net) | |
15.10.24 |
Erste Schätzungen: Hitachi legt Quartalsergebnis vor (finanzen.net) | |
30.07.24 |
Ausblick: Hitachi präsentiert Quartalsergebnisse (finanzen.net) | |
16.07.24 |
Erste Schätzungen: Hitachi veröffentlicht Zahlen zum vergangenen Quartal (finanzen.net) | |
24.06.24 |
Nikkei 225-Wert Hitachi-Aktie: Über diese Dividendenzahlung können sich Hitachi-Anleger freuen (finanzen.at) | |
03.06.24 |
Thales-Aktie gewinnt: Thales verkauft Bahntechnik-Sparte an Hitachi in Milliarden-Deal (dpa-AFX) |
Analysen zu Hitachi Ltd.mehr Analysen
Aktien in diesem Artikel
Hitachi Ltd. | 23,31 | -0,64% |
Indizes in diesem Artikel
NIKKEI 225 | 38 208,03 | -0,37% |